Valuation: Certara, Inc.

Market Cap 157.57Cr 140.71Cr 129.99Cr 117.8Cr 220.39Cr 15TCr 224.04Cr 1.56TCr 619.31Cr 7.84TCr 591.35Cr 578.78Cr 25TCr P/E 2026 *
-46.6x
P/E 2027 * 175x
Enterprise Value 163.55Cr 146.05Cr 134.92Cr 122.27Cr 228.75Cr 16TCr 232.54Cr 1.62TCr 642.8Cr 8.13TCr 613.79Cr 600.74Cr 26TCr EV / Sales 2026 *
4.31x
EV / Sales 2027 * 4x
Free-Float
67.08%
Yield 2026 *
-
Yield 2027 * -
1 day+2.38%
1 week+10.25%
Current month+12.28%
1 month+13.39%
3 months+37.55%
6 months+63.45%
Current year+17.25%
1 week 9.37
Extreme 9.37
10.37
1 month 8.58
Extreme 8.58
10.37
Current year 4.45
Extreme 4.45
10.37
1 year 4.45
Extreme 4.45
12.94
3 years 4.45
Extreme 4.45
19.87
5 years 4.45
Extreme 4.45
45.48
10 years 4.45
Extreme 4.45
45.48
Manager TitleAgeSince
Chief Executive Officer 53 01/01/2026
Director of Finance/CFO 53 15/07/2026
Chief Tech/Sci/R&D Officer - 31/07/2025
Director TitleAgeSince
Chairman 72 01/12/2021
Director/Board Member 68 01/01/2013
Director/Board Member 59 01/08/2017
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/26 Free

Chief Financial Officer

63,532 0.0416%
15/07/26 Other

Chief Financial Officer

1,91,850 0.1233%
01/06/26 Exercice

General Counsel

57,763 0.0371%
Change 5-day change 1-year change 3-year change Capi.($)
+2.38%+10.25%-18.40%-20.66% 157.57Cr
+0.66%-0.86%+0.17%+53.96% 3,89500Cr
+0.29%+5.76%+6.56%+1,162.03% 47TCr
+0.49%-1.61%-55.47%+24.38% 38TCr
+7.22%+11.27%+75.28%+210.92% 31TCr
-0.44%+7.62%-8.12%+71.52% 28TCr
+8.25%+13.27%+95.38%+487.46% 26TCr
+1.25%+11.97%-14.55%+49.91% 16TCr
+4.05%+6.42%+110.37%+221.76% 13TCr
-2.49%+7.59%-25.37%-49.38% 10TCr
Average +2.17%+7.17%+16.58%+221.19% 60.04TCr
Weighted average by Cap. +1.28%+1.91%+6.41%+169.16%

Financials

2026 *2027 *
Net sales 38Cr 34Cr 31Cr 28Cr 53Cr 3.6TCr 54Cr 376.32Cr 148.99Cr 1.89TCr 142.26Cr 139.24Cr 5.94TCr 39Cr 35Cr 32Cr 29Cr 54Cr 3.69TCr 55Cr 385.99Cr 152.82Cr 1.93TCr 145.92Cr 142.82Cr 6.1TCr
Net income -3.08Cr -2.75Cr -2.54Cr -2.3Cr -4.31Cr -292.26Cr -4.38Cr -31Cr -12Cr -153.13Cr -12Cr -11Cr -482.76Cr 42.22L 37.7L 34.83L 31.56L 59.05L 40Cr 60.03L 4.19Cr 1.66Cr 21Cr 1.58Cr 1.55Cr 66Cr
Net Debt 5.98Cr 5.34Cr 4.93Cr 4.47Cr 8.36Cr 567.54Cr 8.5Cr 59Cr 23Cr 297.35Cr 22Cr 22Cr 937.47Cr -1.99Cr -1.78Cr -1.64Cr -1.49Cr -2.79Cr -189.12Cr -2.83Cr -20Cr -7.83Cr -99Cr -7.48Cr -7.32Cr -312.39Cr
Projected Income Statement - Annual - Certara, Inc.
Logo Certara, Inc.
Certara, Inc. is a provider of biosimulation science, technology, and consulting services for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical and biotech industry. The Company's proprietary biosimulation platforms are built on biology, chemistry, and pharmacology principles with proprietary mathematical algorithms that model how medicines and diseases behave in the body. It has developed scientifically-based solutions for the collection, standardization, validation, storage, and analysis of the preclinical, clinical and evidence data needed for MIDD. These data solutions are used internally and industry-wide by life sciences companies. The Company applies AI capabilities within established modeling environments and under the supervision of experienced scientists and regulatory experts. Its modeling platforms and curated datasets position it to incorporate emerging AI techniques in a controlled and scientifically rigorous manner.
Employees
1,546
Date Price Change Volume
23/26/23 $10.33 +2.38% 20,58,599
22/26/22 $10.09 -0.88% 23,65,317
21/26/21 $10.18 +4.04% 17,17,477
20/26/20 $9.785 +3.54% 27,84,588
19/26/19 $9.450 +0.85% 15,04,652
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
MarketScreener Ratings - Certara, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
10.33USD
Average target price
9.168USD
Spread / Average Target
-11.25%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Certara, Inc.
  1. Stock Market
  2. Stocks
  3. CERT Stock